2020 Pilot Awards: Predicting Alzheimer’s, Heart Failure, Understanding Intellectual Disabilities

In July, three new pilot awardees began their UR CTSI-funded projects. Over the next year, the awardees will dissect the cellular and molecular causes of intellectual disabilities and develop new ways to predict Alzheimer's disease in seniors and heart failure in patients who need left ventricular assist devices (LVAD).

New KL2 Career Development Awardees Investigate Lung Disease, Frailty in Colon Cancer Survivors

Congratulations to this year's recipients of the UR CTSI KL2 Career Development Award: Nikesha J. Gilmore, Ph.D. and Matthew D. McGraw, M.D. The award provides two years of support to help early-career scientists obtain independent funding for their innovative research.

UR CTSI Receives Another $24M to Help Researchers Translate Discoveries into Health Improvements

The UR CTSI has been funded for another five years by the National Center for Advancing Translational Science. The $24 million award will allow the institute to continue its efforts to speed the translation of scientific discoveries to the development of therapies that improve health.

UR CTSI Coordinates Coronavirus Research to Maximize Impact

When COVID-19 first hit Rochester, a team of clinicians and researchers – led by the UR CTSI - mobilized to bring the most promising clinical trials to URMC. Since then, UR CTSI has been pivotal in helping researchers quickly adapt and refocus to meet the challenge of the global COVID-19 pandemic.

COVID-19 Biobank Helps Researchers Share Patients’ Samples

The dedicated biorepository will safely collect and store serum, plasma and immune cell samples from COVID-19-positive and -negative patients. Researchers will be able to request access to the samples, which will be linked to the patients’ de-identified clinical data.